Measuring energy expenditure in the intensive care unit: a comparison of indirect calorimetry by E-sCOVX and Quark RMR with Deltatrac II in mechanically ventilated critically ill patients by Martin Sundström Rehal et al.
RESEARCH Open Access
Measuring energy expenditure in the
intensive care unit: a comparison of
indirect calorimetry by E-sCOVX and Quark
RMR with Deltatrac II in mechanically
ventilated critically ill patients
Martin Sundström Rehal1,2*, Erik Fiskaare2, Inga Tjäder1,2, Åke Norberg1,2, Olav Rooyackers2 and Jan Wernerman1,2
Abstract
Background: Indirect calorimetry allows the determination of energy expenditure in critically ill patients by
measuring oxygen consumption (VO2) and carbon dioxide production (VCO2). Recent studies have demonstrated
variable performance of “breath-by-breath” instruments compared to mixing chamber technology. The aim of this
study was to validate two modern devices (E-sCOVX and Quark RMR) against a reference method (Deltatrac II).
Method: Measurements of VO2/VCO2 with the test and reference devices were performed simultaneously over a
20-min period in mechanically ventilated adult intensive care unit patients. Accuracy and precision of instruments
were analyzed using Bland-Altman plots.
Results: Forty-eight measurements in 22 patients were included for analysis. Both E-sCOVX and Quark RMR
overestimated VO2 and VCO2 compared to Deltatrac II, corresponding to a 10 % higher mean resting energy
expenditure. Limits of agreement of resting energy expenditure within ±2 standard deviations were ±461 kcal/24 h
(±21 % expressed as percentage error) for ΔE-sCOVX–Deltatrac II and ±465 kcal/24 h (±22 %) for ΔQuark
RMR–Deltatrac II.
Conclusion: Both test devices overestimate VO2 and VCO2 compared to Deltatrac II. The observed limits of
agreement are comparable to those commonly accepted in evaluations of circulatory monitoring, and
significantly less than results from predictive equations. We hypothesize that the discrepancy between
methods is due to patient/ventilator-related factors that affect the synchronization of gas and spirometry
waveforms.
Trial registration: Australian New Zealand Clinical Trials Registry, Trial ID ACTRN12615000205538. Date
registered 3 March 2015.
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Background
Deciding the optimal provision of energy for patients in
the intensive care unit (ICU) presents an ongoing chal-
lenge to clinicians. Several guidelines recommend a cal-
orie delivery targeted to energy expenditure (EE) [1, 2].
Results from recent large randomized controlled trials
indicate that lower energy targets may be acceptable
during the first weeks of ICU stay, but there is still un-
certainty regarding optimal targets for patients with pre-
existing malnutrition or a prolonged course of critical
illness [3–6]. Regardless of feeding strategy, setting indi-
vidual caloric goals requires an estimation of EE. For this
purpose clinicians have two principal tools. They can
either use equations with inputs from various patient
characteristics, or indirectly measure the metabolic rate
from oxygen consumption (VO2) and carbon dioxide
production (VCO2). Studies comparing predictive equa-
tions to indirect calorimetry (IC) in critically ill patients
show a poor agreement between calculated and mea-
sured EE [7, 8]. Indirect calorimetry allows for accurate
determination of EE, but widespread adoption of the
technique has been limited due to the technical de-
mands of measurements [9].
The Deltatrac Metabolic Monitor (Datex, Helsinki,
Finland) was the first calorimeter validated in ICU pa-
tients, demonstrating high precision and accuracy [10].
It has since been considered the gold standard for gas
exchange measurements during mechanical ventilation.
Deltatrac is no longer in production, highlighting the
need for alternatives. Several devices have recently been
released on the market to meet this demand. A common
feature in modern instruments is that gas exchange is
measured “breath-by-breath”, a technology that requires
software algorithms to synchronize spirometry and gas
concentration measurements. This poses a particular
challenge in the modern ICU, where deep sedation is
rare and the respiratory pattern of patients can be highly
variable. We have previously demonstrated varying
limits of agreement and systematic bias between
Deltatrac and two breath-by-breath instruments when
applied to critically ill mechanically ventilated patients.
These findings have been corroborated by other research
groups [11–13]. This raises concerns about the reliability
of modern calorimeters in this clinical setting. It is
therefore crucial that new technology is evaluated in the
context of its intended use before it is applied to guide
patient care.
The aim of this study is to determine the level of
agreement in gas exchange measurements between
the E-sCOVX (GE, Helsinki, Finland), Quark RMR
(Cosmed, Rome, Italy) and the Deltatrac II in mech-
anically ventilated ICU patients. We hypothesized that
all three instruments would measure VO2, VCO2 and
EE with equal precision and accuracy.
Methods
This study was conducted in a twelve-bed mixed surgical/
medical ICU of a tertiary referral hospital. It was approved
by the regional ethical review board in Stockholm (2014/
1778-31) and registered at Australia New Zealand Clinical
Trials Registry (Trial ID ACTRN12615000205538). Pa-
tients and relatives were informed about the study orally
and in writing before written informed consent was ob-
tained. All mechanically ventilated patients ≥18 years of
age were considered for recruitment. Exclusion criteria
were: 1) gas leaks (chest tubes, pneumothorax, bronch-
oesophageal fistulas, etc; leaks registered by the venti-
lator <10 % of minute volume (MV) were accepted);
2) NO therapy or ECMO 3) fraction of inspired oxygen
(FiO2) >0.60; 4) respiratory rate (RR) >35; and 5) absence
of informed consent. Although continuous renal replace-
ment therapy (CRRT)-induced CO2 diversion can inter-
fere with the accurate determination of metabolic CO2
production, the effect on pulmonary gas exchange mea-
surements should be identical for all instruments. Patients
with CRRT were therefore eligible for inclusion providing
flow rates and filtration remained constant during the
study period. All patients were mechanically ventilated by
Evita XL ventilators (Dräger, Germany) in continuous
positive airway pressure-assisted spontaneous breathing
(CPAP-ASB), biphasic positive airway pressure-assisted
spontaneous breathing (BIPAP-ASB) or mandatory mi-
nute volume ventilation (MMV) modes. When present,
active humidification was turned off at least 30 min prior
to measurements.
All aspects of patient care were ultimately decided by
the attending physician. To avoid excessive changes in
metabolic rate, staff in charge of patients included in the
study were encouraged to keep feeding rates, vasopres-
sor infusions and sedation constant 1 h prior to and
during measurements. Changes in ventilator settings,
endotracheal suctioning, disconnections in the ventilator
circuit or mobilization were avoided unless deemed
urgently required by medical staff. In case of such
events the ongoing measurement was discontinued
and restarted after a 15-min resting period. If unex-
pected deterioration in a patient’s condition required
more extensive interventions by clinical staff the
measurement was aborted. Multiple measurement
series in single patients were performed with a mini-
mum interval of 24 h.
In order to minimize the influence of potential base-
line drift in resting energy expenditure (REE), measure-
ments with the study devices and reference method
were conducted simultaneously as previously described
by Graf et al. [12]. Daily calibrations were performed as
recommended by manufacturers or technical manuals.
All instruments were connected in parallel to the venti-
lator circuit. As this required a temporary disconnection
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of the ventilator and entrainment of room air into the
tubing, a 15-min resting period was mandated before
commencing measurements. This allowed sufficient time
for the mixing chamber of the Deltatrac to equilibrate
with alveolar gas from the patient. The flowmeters of
the COVX and Quark were connected to the y-piece
and expiratory port of the ventilator respectively. The
collection tube for expiratory gas to the Deltatrac mixing
chamber was then attached to the Quark turbine flow-
meter with a plastic adapter. This connection was rein-
forced with duct tape to prevent gas leaks. Gas sampling
lines for both study instruments were connected to the
COVX flowmeter using a three-way stopcock, facilitating
a switch between devices without disconnecting the ven-
tilator. This setup was approved by the manufacturers of
both study devices. An illustration of all connections can
be seen in Fig. 1.
Simultaneous measurements with Deltatrac II and ei-
ther Quark RMR or E-sCOVX were then undertaken for
20 min. After measuring with the first device, another
simultaneous measurement was immediately performed
with the second device and Deltatrac II. Simple com-
puter randomization was used to determine the order of
measurement.
Raw data for all measured parameters were extracted
by software applications from each instrument at the
highest possible sampling rate. As all three systems pro-
vide a different amount of data points over time and
treat artifact suppression differently, we used a standard-
ized approach that was communicated to the manufac-
turers involved prior to the study. When a patient
inhales or exhales sharply (as in the case of coughing)
gas concentrations and spirometry cannot be properly
synchronized, resulting in very low VO2/VCO2 values.
Even though these values are not representative of the
patient’s metabolic state, the contribution of single
artifact data points potentially offsets the average value
of the measurement. The user interface of the E-sCOVX
omits these values when displaying the average over
time, but when raw data is extracted using the manufac-
turer’s software these data points are given a value of
zero. The Quark attempts to calculate VO2/VCO2 from
available parameters, resulting in artifacts with variable
low values. To solve this issue, all data points with
the value zero were omitted in calculations of aver-
ages from the E-sCOVX module. For the Quark RMR
all values which did not fulfil a set of pre-specified
criteria (RR >3/<60, tidal volume >0.2/<3 L, fractional
content of expired CO2 > 0.5/<8 %) were excluded as
artifacts. As the Deltatrac is not affected by small var-
iations in breathing patterns, no method of artifact
suppression was used.
Using the processed data, average values of VO2,
VCO2, MV and respiratory quotient (RQ) were obtained.
REE was calculated using the modified Weir equation,
not accounting for nitrogen excretion. Measurements
where the reference method registered a mean RQ of <0.6
or >1.2 were discarded.
Materials
Deltatrac II Metabolic Monitor
The Deltatrac Metabolic Monitor uses a mixing chamber
technology where all exhaled gas from the patient is col-
lected from the expiratory port of the ventilator. It does
Gas sampling to COVX Gas sampling to Quark Gas collection to Deltatrac mixing chamber 
Flow signal COVX Flow signal QuarkFiO2 Deltatrac







Fig. 1 Schematic illustration of instrument connections to the ventilator circuit. 1. HME Filter. 2. Mainstream capnography to ventilator. 3. COVX
flowmeter. 4. Three-way stopcock. 5. Y-piece. 6. Quark turbine flowmeter. 7. Adapter from calibration syringe. 8. Corrugated tube. 9. Adapter for
Deltatrac FiO2 sampling. 10. Evita XL ventilator. ETT Endotracheal tube, FiO2 fraction of inspired oxygen
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not measure flow directly. Gas from the mixing chamber
is diluted with room air at a constant flow rate and
VCO2 is calculated as the product of flow and the con-
centration of CO2 post-dilution (FCO2). VO2 is then cal-
culated using the Haldane transformation, which
assumes that N2 is biologically inert and present in the
same concentrations in inhaled and exhaled gas. As the
denominator in this equation is (1 – FiO2), VO2 mea-
surements will become increasingly inaccurate as FiO2
approaches 1. It is therefore recommended that mea-
surements are restricted to patients with a maximum
FiO2 of 0.6. It uses a paramagnetic O2 analyzer and an
infrared CO2 analyzer.
Breath-by-breath instruments
The common feature of breath-by-breath systems is
that both flow and gas concentrations are measured
over the respiratory cycle. As there is a delay in gas
concentration measurements due to the transport
time in the sampling lines, flow and gas concentration
curves need to be synchronized by software algo-
rithms. VO2 and VCO2 are then calculated as the
product of volumes and concentrations. Due to the
difficulties of accurately measuring the small differ-
ences in inspired and expired volumes, the assump-
tions of the Haldane transformation are used to allow
for unidirectional flow measurement. This imposes
the same limitations on accuracy at higher FiO2 levels
as with the Deltatrac. As synchronization of gas and
flow measurements become increasingly difficult at
very high respiratory rates, a maximum RR of 35 was
allowed for the purposes of this study.
Quark RMR
The Quark RMR is a breath-by-breath system for gas
exchange measurements. It measures CO2 and O2
concentrations over the respiratory cycle through a
sampling line connected close to the endotracheal
tube. Flow is measured using a turbine flowmeter at-
tached to the expiratory port of the ventilator. There
is a software application to compensate for bias flow
in the ventilator circuit, which has to be set by the
user before the start of every measurement. It uses a
paramagnetic O2 analyzer and an infrared CO2
analyzer.
E-sCOVX
The E-sCOVX module also measures gas exchange
breath-by-breath. Gas samples are drawn from a sam-
pling line connected to the flowmeter and analyzed by
paramagnetic and infrared methods for O2 and CO2, re-
spectively. Flow rates are measured by a pneumotach
flowmeter connected directly to the Y-piece of the venti-
lator circuit.
Statistical analysis
Limits of agreement and bias between VO2/VCO2 as
measured by study instruments (E-sCOVX/Quark RMR)
and the reference method (Deltatrac II) were compared
using Bland-Altman plots [14]. Agreement of REE values
as measured by study devices and the reference method
were also analyzed with the Bland-Altman method, al-
though it is a dependent variable calculated from VO2
and VCO2. A sample size of 50 measurements in at least
20 patients was considered sufficient to determine limits
of agreement within ±2.0 standard deviations (SD). Con-
tinuous variables with parametric distribution were
analyzed for statistical significance using a two-tailed
Student’s t-test for paired samples and Mann-Whitney
U-test for non-parametric data, and an α level of ≤0.05
was considered as statistically significant.
Results
This study was conducted between 27 February 2015
and 5 May 2015. Thirty mechanically ventilated patients
were screened for inclusion. Of these, four did not meet
the clinical inclusion criteria and three did not give con-
sent. A total of 56 measurements were performed during
the study period. Eight measurements were discarded
due to a RQ <0.6 (n = 3), gas leaks >10 % of MV (n = 2),
RR >35 (n = 1), corruption of saved data (n = 1) and proto-
col violation (patient was measured twice in <24 h). Forty-
eight measurements in 22 patients were included for ana-
lysis. Although recruitment fell two cases short of the ini-
tial statistical analysis plan, this had no effect on the
calculations of limits of agreement or confidence intervals.
Patient characteristics are presented in Table 1.
Comparisons between VO2 and VCO2 measurements
from Deltatrac and E-sCOVX/Quark are illustrated in
Bland-Altman diagrams (Figs. 2, 3, 4 and 5). Numerical
comparisons between instruments and predictive
equations are presented in Table 2. There was a sig-
nificant bias towards higher VO2 and VCO2 values
with both E-sCOVX and Quark RMR as compared to
Deltatrac. The precision of measurements with the
study instruments and predictive equations expressed
as limits of agreement (±2 SD) between methods for
VO2, VCO2 and REE are presented in Table 2. The
percentage error (PE = 2 SD/mean value of both
methods) for VO2 was ±23 % for E-sCOVX and ±25 % for
Quark. For VCO2, PE was 19 % for E-sCOVX and 21 %
for Quark. When comparing REE as measured by
Deltatrac II to predictive equations (20 kcal/kg adjusted
body weight/24 h and Harris-Benedict equation), PE
was ±36 % for 20 kcal/kg and ±29 % for Harris-Benedict.
Discussion
The purpose of this study was to validate two new in-
struments for indirect calorimetry against a reference
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method (Deltatrac II) in critically ill mechanically venti-
lated patients. Our results showed a systematic bias to-
wards higher VO2/VCO2 measurements by the breath-
by-breath instruments when compared to the Deltatrac
II. In our patient population this difference corre-
sponded to approximately 10 % of EE. Both devices dis-
played a similar variability of individual measurements,
corresponding to a percentage error in EE of approxi-
mately 20 % compared to Deltatrac.
These results stand in contrast to a previous study by
our group which showed no significant difference in
mean REE between Quark and Deltatrac [11]. We be-
lieve this study is a more accurate representation of the
instrument’s properties for three reasons: 1) Measure-
ments with the reference device were performed simul-
taneously, excluding the possibility that variations in the
patient’s metabolic state affects the two measurements
differently; 2) The Quark bias flow compensation was
more accurate. The level of bias flow was hard to deter-
mine prior to the study due to a variable appearance of
the flow curve at the expiratory valve. A method of vis-
ual assessment for setting the correct compensation was
chosen in dialogue with the manufacturer. After all mea-
surements were completed we were informed that our
ventilators have no bias flow, and the compensation was
retroactively set to zero; and 3) Our previous study did
not account for artifacts, which probably offset mea-
sured VO2/VCO2 towards lower values.
It can be questioned whether Deltatrac II is consid-
ered a gold standard for gas exchange measurements
in this patient group because of its superior accuracy
or merely for historical reasons. A compelling argu-
ment in support of the mixing chamber method is
that it does not require spirometry, only the complete
collection of all expired gas. This eliminates a poten-
tial source of error in the synchronization of flow and
gas concentrations. However, the Deltatrac is an aging
piece of equipment and valid questions can be raised
concerning the effects of time on its measurement
properties. Our own Deltatrac was fully calibrated im-
mediately prior to use and did not show any signs of
deterioration.
We can only hypothesize over potential reasons for
the systematic bias towards higher REE values with the
breath-by-breath instruments. It is unlikely that the ef-
fects of humidity or gas leaks contribute to this result as
these conditions were tightly controlled during measure-
ments. Minute volumes as measured by the test devices
and calculated by Deltatrac were similar, excluding the
potential of a systematic overestimation in spirometry. A
Table 1 Patient characteristics
Characteristic Na
Sex (M/F) 17/5
Age 58.6 ± 15.5













SAPS IIb 68.4 ± 13.8
SOFA (day of measurement) 10.8 ± 4.3
BIPAP-ASB biphasic positive airway pressure-assisted spontaneous breathing,
BMI body mass index, CPAP-ASB continuous positive airway pressure-assisted
spontaneous breathing, MMV mandatory minute volume ventilation, SAPS
Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment
a Values indicated with ± are means ± standard deviation





















Mean VO2 COVX-Deltatrac II
Fig. 2 Bland-Altman diagram of VO2: E-sCOVX–Deltatrac II. Solid line: bias; dashed lines: 95 % confidence interval of bias; semi-dashed lines: limits of
agreement (bias ±2 SD). VO2 oxygen consumption
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potential explanation is that the absence of bias flow
could interfere with synchronization of gas sampling
and flow measurements. At the end of expiration, the
y-piece will contain a small volume of alveolar gas. In
the presence of bias flow this volume is washed out
before the start of inspiration. If it is absent, the first
portion of sampled gas during inspiration will be al-
veolar in composition. As the synchronization algo-
rithm of E-sCOVX assumes a certain inspiratory dead
space volume based on wash-out from bias flow, dif-
ferent inputs could result in an overestimation of
VO2/VCO2. It is possible that the two outliers in the
E-sCOVX measurements were particularly affected by
synchronization issues due to a prolonged period of
zero flow at the end of expiration in relation to re-
spiratory rate [15]. No single ventilatory parameter
could otherwise be correlated to the degree of over-
shoot by breath-by-breath instruments. Although the
validity of this explanation cannot be tested within
the context of this study, it is the most plausible the-
ory available to explain our results. This hypothesis
needs to be tested in future validation studies.
Due to the fundamental differences in the technique
of measuring gas exchange with a mixing chamber and
breath-by-breath instruments, a certain variability in
VO2/VCO2 between simultaneous measurements from
these devices is to be expected. This issue of precision is
likely dependent on patient–ventilator related factors,
such as breathing pattern, respiratory rate and level of
sedation. There is currently no consensus regarding the
magnitude of bias and limits of agreement which can be
considered acceptable in a new device for indirect calor-
imetry. Black and colleagues propose using a maximum
acceptable PE of ±30 % as recommended by Critchley
and Critchley [13, 16]. This cutoff is derived from car-
diac output monitors, where the gold standard of pul-
monary artery catheter thermodilution was assumed to
have a precision (coefficient of variation (CV)) of 20 %.
The PE derived from a Bland-Altman plot can be
regarded as the vector of the precision (CV) of the indi-
vidual instruments. For a new instrument to have an
equal or higher precision than the reference method, the
combined precision as calculated from Pythagoras’ the-























Mean VCO2 COVX-Deltatrac II
Fig. 3 Bland-Altman diagram of VCO2: E-sCOVX–Deltatrac II. Solid line: bias; dashed lines: 95 % confidence interval of bias; semi-dashed lines: limits


















Mean VO2 Quark-Deltatrac II
Fig. 4 Bland-Altman diagram of VO2: Quark RMR–Deltatrac II. Solid line: bias; dashed lines: 95 % confidence interval of bias; semi-dashed lines: limits
of agreement (bias ±2 SD). VO2 oxygen consumption
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using this cut-off as it is possible for the reference
method to have a lower CV than ±20 %, which would
result in a smaller acceptable PE [17]. They recom-
mend determining the precision of the reference tech-
nique within the context of a given study and
calculating the precision of the new technique from
the known CV and PE using a Pythagorean approach.
We have refrained from using this method as the ref-
erence device and the new instruments in our study
calculate VO2/VCO2 from different sets of operands.
It is therefore possible that a discrepancy between
two methods during an individual measurement re-
flects a constant bias present under certain conditions
rather than an imprecision of the new device.
In a similar study to our own, Graf and colleagues
set the recommended limits of agreement at less than
±300 kcals/24 h [18]. This was based on observational
data derived from a study of supplemental parenteral
nutrition, which related an increased rate of infections
to a mean energy deficit of 2300 kcal over 8 days
[19]. Assuming a mean REE of 1500 kcal/24 h, this
would necessitate a PE <20 %. So far, no breath-by-
breath instrument has approached this level of
accuracy when compared to a mixing chamber. The
goal for manufacturers should ultimately be to
achieve the highest attainable agreement between
mixing chamber and breath-by-breath instruments.
However, the possibility remains that a clinically signifi-
cantly lower degree of variability than what has so far been
demonstrated is unachievable in a modern ICU popula-
tion that fulfil inclusion criteria similar to those in our
study. Narrowing the inclusion criteria could possibly re-
sult in better agreement but would limit external validity.
Given the greater influence of respiratory patterns on
breath-by-breath systems, it is important that clinicians
pay close attention to patient–ventilator related factors
that may influence measurement results.
The main strength of our study lies in its robust meth-
odological considerations. The technical setup and con-
ditions for simultaneous measurements were rigorously
controlled to avoid introducing errors that could have
disproportionate effects on certain instruments. Data
was collected at the highest possible sampling frequency
and adjusted for artifacts. Complete recordings of mea-
surements also enabled the manufacturers of tested in-




















Mean VCO2 Quark-Deltatrac II 
Fig. 5 Bland-Altman diagram of VCO2: Quark RMR–Deltatrac II. Solid line: bias; dashed lines: 95 % confidence interval of bias; semi-dashed lines:
limits of agreement (bias ±2 SD). VCO2 carbon dioxide production
Table 2 Precision and bias of VO2 (ml/min), VCO2 (ml/min) and REE (kcal/24 h) between methods
Comparison Mean Bias Precision (bias ±2 SD) PE (±2 SD/mean)
VO2: E-sCOVX–Deltatrac 310 +27 –44 to +98 ±23
VO2: Quark RMR–Deltatrac 301 +25 –49 to +98 ±24
VCO2: E-sCOVX–Deltatrac 245 +37 –8 to +83 ±19
VCO2: Quark RMR–Deltatrac 238 +40 –11 to +90 ±21
REE: E-sCOVX–Deltatrac 2148 +215 –246 to +675 ±21
REE: Quark RMR–Deltatrac 2088 +205 –260 to +670 ±22
REE: 20 kcal/kg/24 h Deltatrac 1754 –559 –1199 to 81 ±36
REE: HBE* Deltatrac 1773 –371 –926 to +183 ±31
* Revised Harris-Benedict equation. N = 46
PE percentage error, REE resting energy expenditure, SD standard deviation, VCO2 carbon dioxide production, VO2 oxygen consumption
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cannot be accessed through the standard user interface.
In contrast to a mixing chamber, the intricacies of
VO2/VCO2 measurements with breath-by-breath tech-
nologies are beyond the scope of clinicians at the
bedside. It is therefore crucial that validation studies
of new instruments pay close attention to the tech-
nical aspects of measurement and potential effects of
patient–ventilator interactions.
The limitation of the study lies in the pragmatic ap-
proach using the standard ventilator without an intrinsic
flow. Therefore, the external validity is limited to the
set-up and protocol of the present study. Nevertheless,
we believe that our study is the most rigorous evaluation
of next-generation indirect calorimeters to date. We rec-
ommend that a similar methodology is used in further
validation studies. Also, our results highlight the import-
ance of new instruments being thoroughly evaluated in
their intended setting before they are used in clinical
practice or research.
Conclusions
Both the E-sCOVX and Quark RMR overestimate VO2
and VCO2 when compared to Deltatrac II. It is likely
that both systematic overestimation and variability in
measurements results from patient- and ventilator-
related factors that do not affect the mixing chamber
technology to a similar extent. Careful consideration to
such factors is essential when designing further valid-
ation studies of indirect calorimeters. The positive bias
corresponding to an overestimation of 10 % in EE is
probably not a clinical problem. The variability (PE) of
20 % is more problematic. However, it compares well
with variability of measurements in circulatory physi-
ology and it is substantially lower that what is reported
for predicted equations.
Key messages
 In the context of our study, the indirect calorimeters
E-sCOVX and Quark RMR measure VO2 and VCO2
with a bias towards higher values and a variability
(percentage error) of approximately ±20 % as
compared to Deltatrac II. This is comparable to
results commonly accepted in circulatory monitoring.
 The result is probably due to patient- and ventilator-
related factors affecting the synchronization of gas
and spirometry waveforms during breath-by-breath
measurements.
 We propose that a similar methodology is used in
future validation studies, and that considerations are
taken to the properties of the ventilator used.
 Validating new indirect calorimeters in the ICU
setting is essential before they are brought into
clinical use.
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